Key facts
- This page summarizes Robert Blanks's Form 4 filing for ARDELYX, INC. (ARDX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 27 Jun 2023, 18:40.
Robert Blanks - 23 Jun 2023 Form 4 Insider Report for ARDELYX, INC. (ARDX)
- Reporting relationship
- Chief Regulatory and Quality Affairs Officer
- Issuer ticker
- ARDX
- Reported as of
- 23 Jun 2023
- Net transaction value
- -$7,043
- SEC form
- 4
- Accepted by SEC
- 27 Jun 2023, 18:40:19 UTC
- Prior SEC filing
- 25 May 2023
- Next SEC filing
- 23 Aug 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Elizabeth Grammer, Attorney-in-Fact for Robert Blanks
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert Blanks filed Form 4 for ARDELYX, INC. (ARDX) on 27 Jun 2023.
Change
- Previous filing in this sequence was filed on 25 May 2023.
- Current net transaction value: -$7,043.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ARDX
transaction
Common Stock
Options Exercise
- Transaction value
- $113,999
- Shares
- +33,333
- Change %
- +13%
- Price
- $3.42
- Shares after
- 299,467
- Date
- 23 Jun 2023
- Ownership
- Direct
- Footnotes
- F1
ARDX
transaction
Common Stock
Sale
- Transaction value
- $121,042
- Shares
- -33,333
- Change %
- -11%
- Price
- $3.63
- Shares after
- 266,134
- Date
- 23 Jun 2023
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ARDX
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -33,333
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 23 Jun 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 33,333
- Exercise price
- $3.42
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 3 footnotes
Footnote F1
This transaction relates an option that would have expired on July 18, 2023 and does not result in a reduction of shares held outright by the Reporting Person. The shares acquired upon the exercise of the option were sold pursuant to a Rule 10b5-1 stock trading plan adopted by the Reporting Person on March 24, 2023. accordingly, the Reporting Person had no discretion with regard to the timing of the transaction.
Footnote F2
This transaction was executed in multiple trades in prices ranging from $3.62 to $3.70, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Footnote F3
The option, which was granted on July 18, 2013, and has an expiration date of July 18, 2023, is fully vested and exercisable.
SEC remarks
Chief Regulatory and Quality Affairs Officer